23Andme Holding Co — Company Overview, News & Financial Data

23andMe (NASDAQ:ME) specializes in personal genetics, combining direct-to-consumer genetic testing with a robust research platform. The company's primary service involves analyzing customers' DNA samples to provide insights into their ancestry, health predispositions, carrier status for certain inherited conditions, and traits. Through its unique business model, 23andMe has amassed a large genetic dataset, enabling the company to also engage in therapeutic research with the aim of discovering and developing novel drugs. One of its key objectives is to make personalized healthcare and genetic information broadly accessible, leveraging its platform to foster a deeper understanding among individuals about their health and heritage. Additionally, 23andMe is committed to pioneering research collaborations and leveraging its genetic database to facilitate scientific discoveries.